NPS Pharmaceuticals Regains Global Rights to Two Orphan Drugs from Takeda
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 4 (Table of Contents)
Published: 4 Apr-2013
DOI: 10.3833/pdr.v2013.i4.1916 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In exchange for US$50 M in common stock, NPS Pharmaceuticals has regained full global rights to two orphan drugs from Takeda Pharmaceutical...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS